SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 80 filers reported holding SPERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $582,989 | -23.2% | 481,809 | -8.0% | 0.00% | – |
Q2 2023 | $759,515 | +6.9% | 523,804 | +6.9% | 0.00% | – |
Q1 2023 | $710,229 | -15.9% | 489,813 | +0.4% | 0.00% | – |
Q4 2022 | $844,383 | -39.0% | 488,083 | -29.5% | 0.00% | – |
Q3 2022 | $1,385,000 | +170.0% | 692,138 | +0.2% | 0.00% | – |
Q2 2022 | $513,000 | -96.7% | 690,753 | -61.5% | 0.00% | – |
Q1 2022 | $15,609,000 | -45.8% | 1,794,081 | -0.3% | 0.00% | -100.0% |
Q4 2021 | $28,799,000 | -13.2% | 1,798,777 | -0.2% | 0.00% | 0.0% |
Q3 2021 | $33,185,000 | +33.6% | 1,802,528 | +1.3% | 0.00% | 0.0% |
Q2 2021 | $24,833,000 | -5.0% | 1,778,822 | +0.1% | 0.00% | 0.0% |
Q1 2021 | $26,152,000 | -22.1% | 1,776,596 | +2.6% | 0.00% | 0.0% |
Q4 2020 | $33,576,000 | +179.3% | 1,731,600 | +60.8% | 0.00% | – |
Q3 2020 | $12,020,000 | -6.5% | 1,077,162 | +13.4% | 0.00% | -100.0% |
Q2 2020 | $12,857,000 | +80.6% | 950,256 | +7.8% | 0.00% | – |
Q1 2020 | $7,120,000 | -1.9% | 881,231 | +16.7% | 0.00% | – |
Q4 2019 | $7,261,000 | +0.9% | 755,265 | +11.2% | 0.00% | – |
Q3 2019 | $7,198,000 | -4.8% | 678,949 | +3.4% | 0.00% | – |
Q2 2019 | $7,559,000 | +40.1% | 656,778 | +56.0% | 0.00% | – |
Q1 2019 | $5,395,000 | +122.8% | 421,087 | +7.0% | 0.00% | – |
Q4 2018 | $2,421,000 | -38.2% | 393,630 | +5.7% | 0.00% | – |
Q3 2018 | $3,915,000 | -22.0% | 372,469 | +8.9% | 0.00% | – |
Q2 2018 | $5,017,000 | +39.5% | 341,999 | +35.6% | 0.00% | – |
Q1 2018 | $3,596,000 | +27.1% | 252,301 | +4.7% | 0.00% | – |
Q4 2017 | $2,830,000 | – | 240,874 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 1,353,303 | $1,637,497 | 13.93% |
Anson Funds Management LP | 4,159,572 | $5,033,082 | 1.01% |
OUP Management Co., LLC | 249,070 | $301,375 | 0.68% |
Atlas Venture Life Science Advisors, LLC | 1,013,438 | $1,226,260 | 0.19% |
Murchinson Ltd. | 862,700 | $1,043,867 | 0.13% |
Alphabet Inc. | 889,979 | $1,076,874 | 0.07% |
AWM Investment Company, Inc. | 333,400 | $403,414 | 0.06% |
DAFNA Capital Management LLC | 125,000 | $151,250 | 0.05% |
Novo Holdings A/S | 468,902 | $567,371 | 0.04% |
XTX Topco Ltd | 58,368 | $70,625 | 0.01% |